Literature DB >> 28088288

A Novel Mouse Model of Staphylococcus aureus Vascular Graft Infection: Noninvasive Imaging of Biofilm Development in Vivo.

Hélène Van de Vyver1, Philipp R Bovenkamp2, Verena Hoerr3, Katrin Schwegmann4, Lorena Tuchscherr5, Silke Niemann6, Laura Kursawe7, Christina Grosse8, Annette Moter7, Uwe Hansen9, Ute Neugebauer10, Michael T Kuhlmann4, Georg Peters11, Sven Hermann4, Bettina Löffler5.   

Abstract

Staphylococcus aureus causes very serious infections of vascular grafts. Knowledge of the molecular mechanisms of this disease is largely lacking because of the absence of representable models. Therefore, the aim of this study was to set up a mouse model of vascular graft infections that closely mimics the human situation. A catheter was inserted into the right carotid artery of mice, which acted as a vascular graft. Mice were infected i.v. using 8 different S. aureus strains, and development of the infection was followed up. Although all strains had varying abilities to form biofilm in vitro and different levels of virulence in mice, they all caused biofilm formation on the grafts. This graft infection was monitored using magnetic resonance imaging (MRI) and 18F-fluordeoxyglucose positron emission tomography (FDG-PET). MRI allowed the quantification of blood flow through the arteries, which was decreased in the catheter after infection. FDG-PET revealed high inflammation levels at the site of the catheter after infection. This model closely resembles the situation in patients, which is characterized by a tight interplay between pathogen and host, and can therefore be used for the testing of novel treatment, diagnosis, and prevention strategies. In addition, combining MRI and PET with microscopic techniques provides an appropriate way to characterize the course of these infections and to precisely analyze biofilm development.
Copyright © 2017 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28088288     DOI: 10.1016/j.ajpath.2016.10.005

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  6 in total

Review 1.  Oral Biofilms: Pathogens, Matrix, and Polymicrobial Interactions in Microenvironments.

Authors:  William H Bowen; Robert A Burne; Hui Wu; Hyun Koo
Journal:  Trends Microbiol       Date:  2017-10-30       Impact factor: 17.079

Review 2.  Biofilms: Formation, Research Models, Potential Targets, and Methods for Prevention and Treatment.

Authors:  Yajuan Su; Jaime T Yrastorza; Mitchell Matis; Jenna Cusick; Siwei Zhao; Guangshun Wang; Jingwei Xie
Journal:  Adv Sci (Weinh)       Date:  2022-08-28       Impact factor: 17.521

3.  Comparative in vitro activity of bacteriophage endolysin HY-133 against Staphylococcus aureus attached to vascular graft surface.

Authors:  Evgeny A Idelevich; Dennis Knaack; Nyityasmono Tri Nugroho; Georg Peters; Theodosios Bisdas; Sonja Molinaro; Giovanni B Torsello; Karsten Becker; Monika Herten
Journal:  Med Microbiol Immunol       Date:  2019-10-17       Impact factor: 3.402

4.  Multimodal Tracking of Controlled Staphylococcus aureus Infections in Mice.

Authors:  Mick M Welling; Clarize M de Korne; Silvia J Spa; Danny M van Willigen; Albertus W Hensbergen; Anton Bunschoten; Nikolas Duszenko; Wiep Klaas Smits; Meta Roestenberg; Fijs W B van Leeuwen
Journal:  ACS Infect Dis       Date:  2019-05-02       Impact factor: 5.084

5.  Host-pathogen interactions of clinical S. aureus isolates to induce infective endocarditis.

Authors:  Christian Schwarz; Yasemin Töre; Vanessa Hoesker; Sabine Ameling; Katja Grün; Uwe Völker; P Christian Schulze; Marcus Franz; Cornelius Faber; Frieder Schaumburg; Silke Niemann; Verena Hoerr
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

Review 6.  A Narrative Review of Experimental Models to Study Vascular Grafts Infections.

Authors:  Mathilde Puges; Fatima M'Zali; Sabine Pereyre; Cécile Bébéar; Charles Cazanave; Xavier Bérard
Journal:  EJVES Vasc Forum       Date:  2022-03-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.